Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Seems like yet another management failure to raise funds

<< Previous

Bullboard Posts

Next >>

Comment by Dumbeldorfwhiteon Sep 10, 2024 2:34pm

172 Views

Post# 36217095

RE:RE:RE:RE:Seems like yet another management failure to raise funds

Yeah except for they get insane amounts of option packages without, in my opinion, being tied to any sort of performance incentives. So in other words it's a joke and of course then they can vote for the aforementioned options package every year. I ve voted the entire board a NO the past 3 years along with the options packages.

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale